Noroviruses can establish chronic infections with active viral shedding in healthy humans but whether persistence is associated with adaptive immune dysfunction is unknown. We used genetically engineered strains of mouse norovirus (MNV) to investigate CD8 + T cell differentiation during chronic infection. We found that chronic infection drove MNV-specific tissue-resident memory (Trm) CD8 + T cells to a differentiation state resembling inflationary effector responses against latent cytomegalovirus with only limited evidence of exhaustion. These MNV-specific Trm cells remained highly functional yet appeared ignorant of ongoing viral replication. Pre-existing MNV-specific Trm cells provided partial protection against chronic infection but largely ceased to detect virus within 72 hours of challenge, demonstrating rapid sequestration of viral replication away from T cells. Our studies revealed a strategy of immune evasion by MNV via the induction of a CD8 + T cell program normally reserved for latent pathogens and persistence in an immune-privileged enteric niche.
INTRODUCTION
Noroviruses (NVs) are major global pathogens that cause an estimated 267 million infections and 200,000 deaths each year (Debbink et al., 2012) . Vaccine efforts have shown promise, but complete protection against homologous challenge has not been achieved (Atmar et al., 2011) . Moreover, volunteer and epidemiologic studies have generated conflicting data regarding the durability and protective capacity of NV immunity, while recent reports of persistent NV shedding by immunocompetent individuals have challenged the traditional view of NVs as acute and self-limited pathogens (Karst et al., 2014) . These data suggest the existence of viral mechanisms of immune evasion, however the immunological determinants of NV clearance versus persistence remain poorly understood. Most studies have used antibodies as markers of pre-existing NV immunity and have shown that, depending on the setting, such responses are neither necessary nor sufficient for protection (Atmar et al., 2011) . In contrast, cellular immunity, particularly at mucosal sites, remains largely unexplored.
We and others have used the mouse model of NV infection (MNV) to study MNV clearance versus persistence (Tomov et al., 2013) . Early studies showed that all aspects of adaptive immunity are required for clearance of the non-persisting strain MNV-CW3 (Karst et al., 2014) . On the other hand, a related strain, MNV-CR6, causes chronic infection even in immunocompetent mice. Recent studies have shown that MNV-CR6 persistence depends on the enteric microbiota and can be prevented by pre-treating mice with antibiotics Jones et al., 2014) . It remains to be defined whether these findings reflect direct bacterial-viral interactions (Kuss et al., 2011) or commensal modulation of the host antiviral immune response (Abt et al., 2012) . In addition, persistent MNV-CR6 infection can be cleared by exogenous interferon-lambda , however this phenomenon is mediated by innate immunity and does not afford protection against subsequent re-challenge with the same strain. Thus, adaptive immune responses will be necessary to achieve durable immunity against MNV.
A key challenge to understanding MNV persistence is our limited knowledge of the host-pathogen interactions responsible for immune failure during chronic infection. Myeloid cells, B cells, and epithelial cells can support mouse and/or human NV replication in cell culture (Ettayebi et al., 2016; Jones et al., 2014) , but the relevance of these cell types to persistence in vivo is unclear, and the precise cellular identity and anatomical location of the viral reservoir remain unknown. The identification of CD300lf as an MNV cellular receptor is a major step toward addressing this issue (Orchard et al., 2016) . However, it is unclear whether CD300lf is sufficient to explain viral replication during established chronic infection as CD300lf expression is largely restricted to dendritic cells (DCs) (Gasiorowski et al., 2013) but persisting MNV-CR6 replicates in nonhematopoietic cells in vivo .
In previous studies, we demonstrated that the non-persisting strain MNV-CW3 induces robust virus-specific CD8 + T cell responses in the intestine (Tomov et al., 2013; Osborne et al., 2014) . In contrast, infection with the persisting strain MNV-CR6 is associated with substantially fewer and less-functional virusspecific CD8 + T cells, suggesting that suboptimal T cell responses might contribute to viral persistence (Tomov et al., 2013) . However, as the sequence of the immunodominant P1 519 epitope differs between these two MNV strains, it was unclear whether the weak CD8 + T cell response to MNV-CR6 was due to intrinsic CD8 + T cell dysfunction or suboptimal epitope
binding. In the current study, we have addressed this issue by engineering acute and chronic MNV strains that share the same immunodominant CD8 + T cell epitope. Using these strains, we demonstrate that improving the magnitude of the primary CD8 + T cell response did not prevent viral persistence. Moreover, virus-specific CD8 + T cells from chronic MNV infection developed a distinct transcriptional and phenotypic signature compared to memory CD8 + T cells generated during acutelyresolved infection. These cells showed strong similarity to inflationary effector CD8 + T cells responding to mouse cytomegalovirus (MCMV) infection. Consistent with these transcriptional features, virus-specific CD8 + T cells from chronic MNV infection remained responsive to antigen upon re-exposure, indicating that they retained functionality. MNV-specific memory CD8 + T cells mediated initial protection from challenge with a persisting MNV strain but in most cases this protection was short-lived. Analysis of early events following challenge of immunized mice revealed a marked deficiency in the ability of MNV-specific CD8 + T cells to respond to the chronic strain of MNV. Rather, during chronic infection, MNV-specific CD8 + T cells were largely ignorant of ongoing viral replication in vivo. Moreover, MNV-specific CD8 + T cells also failed to respond in vitro when co-cultured with intestinal cells from chronically infected mice unless the intestinal cells were first lysed to release antigen. Collectively our findings show that MNV persistence was associated with a unique differentiation state of virus-specific CD8 + T cells. While such cells could, in some settings, confer protection against MNV, T cell ignorance emerged early during chronic infection, likely due to the establishment of an immunoprivileged enteric niche that supported long-term viral replication. These findings further provide an explanation for the emergence of chronic NV infections and might help explain heterogeneous responses in humans.
RESULTS

Single Amino Acid Determines the Magnitude and Function of MNV-Specific CD8 + T Cells
We previously mapped a conserved immunodominant epitope (
) that accounts for $80% of the total CD8 + T cell response against MNV ( Figure S1A ; Tomov et al., 2013 Figure 1A ). These reverse engineered viruses grew with normal kinetics in the mouse macrophage-like RAW-264.7 cell line indicating that the changes in P1 519 did not affect viral fitness in vitro ( Figure 1B Figure S1C ) or affect the overall antibody response ( Figure S1D ). Thus, position 7 of P1 Figure 2A ). Genes that were downregulated during MNV-CR6 F/Y infection included Il2, Sipr1, Tcf7, Lef1, Btla, Cxcr4, Slamf6, Ly6c2, Cd40lg, Klrk1, and Pdcd1 (Figure 2A) .
Gene set enrichment analysis (GSEA) using gene ontology (GO) terms indicated that Tet + CD8 + T cells from chronically-infected mice were mitotically and metabolically active and upregulated genes involved in cell division, aerobic respiration, and lipid metabolism ( Figure 2B ). On the other hand, Tet + memory CD8 + cells from resolved MNV-CW3 WT infection upregulated genes associated with adaptive immune responses, T cell receptor (TCR) signaling, and cytokine production ( Figure 2C) Figure 2A ).
Moreover, protein expression correlated with transcriptional differences for a number of differentially transcribed genes (Figure 2D) . In sum, these data indicate an unusual differentiation state of MNV-specific CD8 + T cells compared to typical exhausted CD8 + T cells defined in studies of chronic LCMV and HIV infection (Wherry and Kurachi, 2015) . (Tomov et al., 2013 Figure 3C ). In contrast to CD103, CD11a, and CD49d were more highly expressed on Tet + CD8 + T cells from MNV-CW3 WT compared to MNV-CR6 F/Y infection ( Figure 3D ), consistent with differences between the WT strains (Tomov et al., 2013 (Bergsbaken and Bevan, 2015) . Alternatively, the CD103 lo Tet + CD8 + T cells from MNV-CW3 WT -infected mice might be recirculating T cells rather than true Trm cells (Carbone et al., 2013) . To distinguish between these possibilities, we used intravascular staining for CD8a (Beura et al., 2015) , which distinguished between anatomic compartments with different access to the circulation ( Figure 3E , CD8a + versus CD8a À cells).
In the intestine, 99% of CD8 + LPL and IEL were inaccessible to the i.v. administered antibody indicating that they were not from blood contamination ( Figure 3E , green gates). Furthermore, these gut-associated lymphocytes contained both CD103 lo and
CD103
hi Tet + cells, suggesting that both CD103-defined subsets were Trm cells ( Figure 3F ). To further investigate MNV-specific CD8 + T cell tissue residence, we applied GSEA using a Trm cell signature . Next, we defined transcriptional signatures of CD8 + T cells responding to persisting or resolved MNV infection using differentially expressed genes at day 30 p.i. (Figure 2A ). We tested for enrichment of these MNV signatures in the transcriptional profiles of CD8 + T cells from acute versus chronic lymphocytic choriomeningitis virus (LCMV) infection . Indeed, GSEA revealed enrichment for the MNV-CR6 F/Y signature in CD8 + T cells from chronic LCMV infection ( Figure S4A ).
Conversely, the MNV-CW3 WT signature was enriched in functional memory CD8 + T cells from resolved LCMV infection (Figure S4B ). The transcriptional similarity between CD8 + T cells responding to chronic MNV and LCMV infections was driven, in part, by genes encoding exhaustion markers Tim3 and 2B4, integrin CD49b, and cytokine CXCL10 ( Figure S4A ). However, genes for other key markers of exhaustion, such as Pdcd1, were not part of the MNV-CR6 F/Y CD8 + T cell signature and did not contribute to core enrichment in Figure S4A . To investigate this question further, we used published immunologic signatures to perform comprehensive GSEA of Tet + CD8
+ T from day 30 MNV-CR6 F/Y infection. There was significant enrichment of several exhaustion signatures derived from the LCMV model ( Figure 4A ) consistent with Figure S4A West et al., 2011) . However, the transcriptional profile of Tet + CD8 + T was also enriched for effector signatures ( Figure Figure S4C ). Given the preserved effector features of Tet + CD8 + T cells from chronic MNV infection, we considered the murine cytomegalovirus (MCMV) model of viral persistence that is characterized by latency and reactivation. These viral dynamics give rise to inflationary virus-specific CD8 + T cells that maintain an effector phenotype and do not become exhausted despite repeated antigenic stimulation (Snyder, 2011) . GSEA showed enrichment of an inflationary effector CD8 + T cell signature (Quinn et al., 2015) in the transcriptional profile of CD8 + T cells responding to persistent MNV-CR6 F/Y infection ( Figures 4D and S4D ), suggesting long-term maintenance of a functional effector CD8 + T cell (Teff cell) response. Indeed, the normalized enrichment scores (NES) for effector signatures in Figures 4B and 4D were higher than the NES for exhaustion signatures in Figure 4A ( Figure 4E) . Moreover, of the 45 genes that contributed to core enrichment of the MCMV Teff cell signature ( Figure S4D ), 18 (40%) also contributed to enrichment of other effector signatures ( Figure 4F ) while none contributed to enrichment of exhaustion signatures. Therefore, the transcriptional similarities between CD8 + T cells responding to chronic MNV and latent MCMV infection can be largely attributed to effector genes. Phenotypic features of inflationary CD8 + T cells include upregulation of granzyme and CX3CR1 and downregulation of the co-stimulatory molecules CD27, CD28, and GITR (Snyder, 2011; van de Berg et al., 2012; Welten et al., 2013 , these cells did not expand in number and were difficult to detect 5 days post transfer ( Figure 5C ). In a few chronically infected recipients, donor Tet + CD8 + T cells could be found in the intestine but these cells had not divided and accounted for less than 10% of all donor CD8 + T cells ( Figure 5D ), suggesting they had not encountered antigen. Consistent with this conclusion, viral loads in these mice remained unchanged after the adoptive transfer (data not shown).
The failure of adoptively transferred Tet + CD8 + T cells to respond to MNV-CR6 F/Y suggested that these cells were ignorant of persisting antigen. Alternatively, poor donor responses might be due to competition from pre-existing host CD8 + T cells (Quinn et al., 2015) . Therefore, we repeated the adoptive transfer experiment in Figures 5A-5C using Thy1.1 (recipients) and Thy1.2 (donors) as congenic markers, and used an antiThy1.1 antibody to selectively deplete host T cells from recipients prior to the adoptive transfer ( Figures S5A and S5B ). Five days post transfer, donor Thy1.2 + CD8 + T cells were detected in all tissues examined but had not proliferated significantly in most mice ( Figure S5C ). Depletion of host T cells did enhance overall donor cell survival, especially in MLN, however this effect was modest and observed in both naive and chronically-infected mice, suggesting homeostatic proliferation rather than an antigen-specific response ( Figure S5C) . Indeed, most CTV-low donor CD8 + T cells were not Tet + in either naive or CR6 F/Yinfected mice ( Figure 5E-5F ). Adoptively-transferred CD8 + T cells were most abundant in the MLN of 2 out of 5 persistently infected Thy1.1-depleted recipients ( Figure S5C , blue circles in MLN plot), however even in these mice Tet + cells accounted for less than 0.5% of total donor cells ( Figure 5H ). Similarly, Tet + cells accounted for at most 11% of donor CD8 T cells in the IEL and this was seen in just 1 out of 5 recipients ( Figure 5H Figure 5H ). Compared to Figure 5B , donor Tet + cell expansion was less robust (red bars in Figure 5H versus 5D), consistent with the different timing of these adoptive transfers (recipient mice day 4 p.i. in Figure 5B versus day 1 p.i. in Figure 5H ) and the fact that MNV-CW3 WT viral titers peak at $day 4 (data not shown). Collectively, these data demonstrate that despite having the capacity to respond to antigen in vivo, virus-specific CD8 + T cells fail to do so during chronic MNV-CR6 F/Y infection and this defect is not due to T cell competition.
Therefore, Tet + CD8 + T cells in persistently infected mice might be limited by an inability to efficiently detect viral antigen.
Preexisting CD8 + T Cell Immunity Confers Partial
Protection against Chronic MNV Given the response of Tet + CD8 + T cells to MNV-CW3 WT (Fig- ure 5B), we tested the effectiveness of pre-existing immunity against MNV-CR6 -immune mice and report all outcomes based on the chronic strain used in the challenge.
As expected, all non-immunized mice became chronically infected when challenged with MNV-CR6
WT or MNV-CR6 most cases replication of the challenge MNV-CR6 F/Y virus eventually rebounded. However, $1/3 of animals achieved long-term viral control with undetectable titers in the stool for at least $30 days despite being co-housed with mice who remained infected and shedding virus ( Figure 6A ). At day 30 post challenge, these protected mice also had undetectable viral titers in the proximal colon ( Figure 6B ).
These data showed that early viral control following MNV-CR6 F/Y challenge was universal, whereas long-term protection was sporadic ( Figure 6C ). Figure 6B ) the F/Y mutation was preserved at day 30 post challenge (Figure 6D) . Similarly, MNV-CR6 F/Y sequences from the fecal pellets of 4 other primed and chronically-infected mice also contained the F/Y mutation (data not shown). These findings further suggested that CD8 + T cells failed to exert immune pressure on MNV-CR6 F/Y in the chronic phase of infection. In 2 of the primed and chronically infected mice, the P1 519Y epitope had, in fact, mutated back to P1 519F ( Figure 6D ). Moreover, this was a true reversion since the Phe codon in these mutant sequences was TTC, whereas it is TTT in the wild-type CR6 strain (compare to Figure 1M ). We hypothesize that this sequence change represents an alternative pathway of viral escape early after challenge when CD8 + T cells exerted some degree of control over viral replication.
As partial protection against chronic MNV was observed for MNV-CR6 F/Y but never for MNV-CR6 WT or in unimmunized mice, we surmised that such protection was mediated by CD8 + T cells. To directly test this conclusion, we depleted a subset of immunized mice of CD8 + T cells ( Figure S6C ) and measured viral titers at early time points post MNV-CR6 F/Y challenge. Consistent with our previous observations, immunized mice with intact CD8 + T cells controlled viral replication at early time points ( Figure 6E , squares). By contrast, most mice treated with anti-CD8b had high viral titers in the proximal colon at days 4 and 6 post challenge ( Figure 6G , triangles). Of note, we did not detect MNV in the liver or spleen of these CD8-depleted mice, consistent with the gut-specific tropism of MNV-CR6 (Nice et al., 2013 (Figure 6A ), while the adoptive transfers suggested that these cells were ignorant of viral replication during chronic infection ( Figure 5C ). To investigate these dynamics further, we generated a recombinant vaccinia virus expressing the P1 519Y epitope (rVV 519Y ) and used it to boost the P1 519 -specific CD8 + T cell response in MNV-CW3 WT -immune mice ( Figures S6A-S6B Figure 7B ).
These, donor Tet + CD8 + T cells homed to the spleen and MLN, as well as to the intestinal mucosa and LP where they accumulated to the highest frequency ( Figure 7G (Zhu et al., 2016; Zhu et al., 2013) . To distinguish between these possibilities, we designed an in vitro experiment to ''force'' interactions between Tet Figure 7J ). Similar results were obtained when bone marrow-derived DCs were used as APC ( Figure S7 ). Moreover, proliferation of Tet + CD8 + T cells in these in vitro assays was antigen-specific, as it was not observed with lysed intestinal preps from naive mice ( Figure S7A ). These data suggested restricted availability and/or release of viral antigen from the intestinal cellular reservoir despite continued replication of MNV-CR6 F/Y in vivo. Taken together, our in vivo and in vitro experiments support a mechanism of CD8 + T cell evasion by MNV based on persistence in an immune-privileged enteric niche.
DISCUSSION
Two challenging aspects of NV biology have recently been appreciated. First, NVs cause chronic infections in some immunocompetent individuals thereby creating a potential reservoir for viral evolution and spread (Karst et al., 2014) . Second, NVs evade adaptive immune responses even in previously vaccinated individuals who have robust NV-specific antibody titers (Atmar et al., 2011) . Understanding why adaptive immunity fails to prevent or clear NV infections can facilitate future vaccine and public health efforts. CD8 + T cells are critical for control of many mucosal pathogens including NVs (Chachu et al., 2008) . However, the impact of chronic enteric infection on Trm cell responses and differentiation remains poorly understood. As chronic viral infections are often facilitated by T cell dysfunction, defining the features of T cell failure could have implications for therapeutic interventions and preventative vaccines. Using the MNV model we discovered two key features of the CD8 + T cell response and protective immunity during chronic infection. First, MNV-specific CD8 + T cells retained functional responsiveness and did not display typical features of exhaustion. Indeed, MNV-specific CD8 + T cells maintained transcriptional features of activation resembling inflationary effector CD8 + T cells from herpesvirus infections. Second, there was a narrow window of opportunity for CD8 + T cells to exert protection against chronic MNV infection, leading to an apparent paradox of continued robust viral replication despite a largely functional antiviral CD8 + T cell response. Our findings point to a mechanism of largely immunologically undetectable persistence of an RNA virus in the intestinal tract.
Although pathogen persistence is not unique to MNV, our data suggest an unusual pattern of immune evasion. First, the immunodominant P1 519Y epitope did not revert to the less immunogenic 519F variant following primary and most secondary infections, suggesting that antigenic escape is not a major pathway facilitating MNV persistence. Second, CD8 + T cell exhaustion or senescence did not develop in P1 519Y -specific CD8 + T cells, as these cells remained functional even after 30 days of chronic infection. Third, overt tolerance to MNV-CR6 F/Y also appears unlikely given the absence of Treg cell expansion and the robust response of P1 519Y -specific CD8 + T cells when adoptively transferred to MNV-CW3 WT -infected mice.
A fourth possibility is that Tet + CD8 + T cells fail to clear MNV-CR6 F/Y due to limited access to viral antigen during chronic infection. True CD8 + T cell ignorance is thought to arise from insufficient anatomical access to antigen and/or lack of costimulatory signals (Woodham et al., 2016) . However, in the case of established chronic MNV-CR6 F/Y infection, the effector properties of P1 519 -specific CD8 + T cells and their transcriptional similarity to inflationary MCMV-specific responses suggest that these cells do, at least occasionally, encounter and respond to antigen in vivo, but such interactions might be transient and/or inefficient. How does a virus persistently replicating at high levels induce a CD8 + T cell transcriptional program normally reserved for latent pathogens? MNV cellular tropism might be at the core of this question and while the identity of the in vivo cellular reservoir remains poorly understood, our data might be relevant for elucidating the pathogenesis of this chronic enteric infection. Although we demonstrate a role of CD8 + T cells in preventing chronic MNV infection, at least in some mice, our data also show that these cells have a narrow window of opportunity to prevent persistence. This observation suggests a possible ''switch'' in tropism associated with the transition to viral persistence. CD300lf + DCs can support MNV-CR6 infection in vitro and might be necessary for at least the initial establishment of infection in vivo (Orchard et al., 2016) . Thus, one possibility is that initial DC infection allows priming and early control of MNV-CR6 F/Y infection by CD8 + T cells, but subsequently viral persistence is established in a cell type that is relatively inaccessible or unrecognizable by Tet + CD8 + T cells. The transcriptional program of MNV-specific CD8 + T cells from chronic infection does, however, implicate occasional re-stimulation with antigen in vivo perhaps due to low-level release from the viral reservoir. Moreover, the CD103 status of MNV-specific CD8 + T cells in acutely resolved versus chronic infection might be relevant. For example, data from the Yersinia model show that the physical proximity of CD103 lo Trm cells to antigen-presenting cells is critical for successful pathogen clearance (Bergsbaken and Bevan, 2015) . Whether the distinct patterns of CD103 expression on Tet + CD8 + T cells from resolved versus chronic MNV infection reflect differences in viral tropism and local immune environment, and whether modulating this axis could have antiviral effects will be interesting to interrogate in the future.
We have shown that a robust and functional CD8 + T cell response fails to prevent MNV persistence. The behavior of MNV-specific CD8 + T cells during chronic infection suggests a ''blind spot'' in their ability to perceive antigen. Whether such ignorance is the result of a maladaptive CD8 + T cell differentiation pattern or viral replication inside an immunoprivileged enteric niche remains to be determined and will have important implications for the design of future NV vaccines.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents may be directed to Vesselin Tomov (tomovv@pennmedicine.upenn.edu)
EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
Wild-type C57BL/6J female mice age 6-8 weeks were obtained from Jackson Laboratory, Bar Harbor, ME. MNV-free status of mice from Jackson Laboratory was confirmed by serology testing and qPCR. After arrival, mice were maintained MNV-free in designated cages with bedding and food changes done separately from other mice by the investigators. Periodic monitoring of naive controls was carried out to confirm MNV-free status. Mice were infected by oral gavage with 1x10 6 PFU of MNV delivered in 200 ml culture medium (RPMI with 10% fetal bovine serum). For vaccinia virus boost experiments, mice were injected intraperitoneally with 1x10 6 PFU of rVV 519Y in 200 ml culture medium. All mice were used in accordance with Institutional Animal Care and Use Committee guidelines for the University of Pennsylvania.
Mouse Noroviruses MNV strains CW3 Y/F and CR6 F/Y were generated from the parental strains MNV-1.CW3 (GenBank: EF014462) and MNV-1.CR6
(GenBank: EU004676). Overlap extension PCR was used to generate fragments containing the Y/F or F/Y mutations as previously described (Higuchi et al., 1988) . For MNV-CW3 Y/F , primers (5 0 -CCCCTTGCCCCCCCAATTGGTCCC-3 0 ) and (5 0 -GGCCAATT GAAAAAGGCGAGGAACCCAACTGACGACC-3 0 ) were used to generate the first fragment, and primers (5 0 -CCTCGCCTTTTT CAATTGGCCTCTGTGGGAAGTTTGGC-3 0 ) and (5 0 -GGAGTGAATTCTAGCGGCCGCTAGAATTCCG-3 0 ) were used to generate the second fragment. The product from the overlap extension step was cloned into the MNV-CW3 backbone between endonuclease restriction sites ApaL1 and Not1. For MNV-CR6 F/Y , primers (5 0 -CCCCTTGCCCCACCCCTAGGCCCC-3 0 ) and (5 0 -CGGAGGC CAATTGGTAGAGGCGGGGGACCCAGCTGACAACC-3 0 ) were used to generate the first fragment, and primers (5 0 -GCCTCTAC CAATTGGCCTCCGTGGGAAGCTTGG-3 0 ) and (5 0 -GGAGTGAATTCTAGCGGCCGCTAGAATTCCG-3 0 ) were used to generate the second fragment. The product from the overlap extension step was cloned into the MNV-CR6 backbone between endonuclease restriction sites Pvu1 and Not1. All constructs were sequenced to confirm successful insertion of the mutant sequences. Viral stocks of the wild-type and mutant viruses were generated by transfecting virion-encoding plasmids into 293T cells and transferring supernatant onto RAW 264.7 cells as previously described (Tomov et al., 2013) . Briefly, 293T cells were transfected using FuGENE-HD reagent (Promega, Madison, WI) according to the manufacturer's protocol (FuGENE:DNA ratio of 5:2). After 48 hours, transfected 293T cells were lysed by freeze-thaw, cellular debris was removed by centrifugation (10 minutes, 3,000 g, 4 C), and the supernatant was transferred onto RAW 264.7 cells that had been plated at 2x10 6 cells/well in 6-well plates 24 hours earlier. After 48 hours, RAW 264.7 cells were freeze-thawed and supernatant was purified from cellular debris as above. Viral stock titers were determined by plaque assay on RAW264.7 cells. 
Recombinant Vaccinia Virus
Recombinant vaccinia virus rVV 519Y was generated by cloning an insert containing the P1 519Y sequence between restriction sites EcoR1 and Nhe1 in vector pRB21 (Blasco and Moss, 1995) . Top (5 0 -AATTCATGAGTTGGGTTCCTCGCCTTTACCAATTGTAG-3 0 ) and bottom (5 0 -CTAGCTACAATTGGTAAAGGCGAGGAACCCAACTCATG-3 0 ) oligonucleotides were annealed and 5 0 phosphate groups were added using T4 polynucleotide kinase prior to cloning into the pRB21 vector. Successful insertion was confirmed by DNA sequencing. Recombinant vaccinia virus was produced by homologous recombination in CV-1 cells and triple plaque purification on 143B cells in the presence of 5mg/ml 5 0 -bromo-2 0 -deoxyuridine as previously described and additional stocks were prepared in BSC40 cells (Wherry et al., 2001) .
METHOD DETAILS Lymphocyte Isolation and Flow Cytometry
Lymphocyte isolation from spleens, mesenteric lymph nodes, intestinal epithelium, and intestinal lamina propria was performed as previously described (Tomov et al., 2013) . Briefly, spleens, and mesenteric lymph nodes were harvested in 2 mL cold (4 C), sterile culture media (RPMI with 10% fetal bovine serum), and homogenized through 70 mm cell strainers. In the case of spleens, red blood cells were lysed with ammonium-chloride-potassium (ACK) lysing buffer (Life Technologies, Grand Island, NY) for 2 minutes, and washed in cell culture media. Small intestines were dissected free of fat and Peyer's patches, cut open longitudinally, washed clean of fecal material in PBS, and placed in 10 mL cold culture media. To remove epithelial cells, intestines were incubated in stripping buffer (PBS containing 5 mM EDTA, 1 mM dithiothreitol, 5% fetal bovine serum, 100 IU/ml penicillin, and 100 mg/ml streptomycin) and shaken at 160 rpm for 10 minutes at 37 C. After discarding the supernatant, intestines were incubated again in stripping buffer and shaken at 160 rpm for 20 minutes at 37 C. The supernatant containing intestinal epithelial cells (IEL) was passed through a 70 mm cell strainer, washed in culture media, re-suspended in culture media containing 40% Percol, and subjected to centrifugation at 600 g, room temperature, for 20 minutes (without break). Following centrifugation, the supernatant was carefully removed and cell pellets were washed in culture media. After IEL stripping, lamina propria lymphocytes (LPL) were isolated by incubating intestines in cell media containing 0.5 mg/ml collagenase/dispase (Genetech, South San Francisco, CA) and 20 mg/ml DNaseI (Sigma-Aldrich, St. Louis, MO) for 20 minutes at 37 C and shaking at 160 rpm. LPL were passed through a 70 mm cell strainer, washed, and centrifuged in 40% Percol as described above. LPL and IEL were isolated from the small intestine except in Figure 3B where they were isolated from the colon. In vitro stimulation with peptides P1 519F and P1 519Y was carried out for 5 hours at 37 C with 0.4 mg/ml of peptide in the presence of GolgiStop and GolgiPlug (BD Biosciences, San Diego, CA) as previously described (Tomov et al., 2013) . Cells were fixed and permeabilized using a Cytofix/Cytoperm kit (BD Biosciences, San Diego, CA) or FoxP3 Fixation/Permeabilization kit (eBioscience, San Diego, CA) according to the manufacturer's protocol. MHC Class I-peptide tetramers used in this study have been previously described (Tomov et al., 2013) . Antibodies used are documented in the Key Resource Table. Data analysis was performed using FlowJo (version 10.3) software (LLC, Ashland, OR). Dead cells were removed by gating on a LIVE/DEAD Aqua kit (Invitrogen, Carlsbad, CA) versus forward scatter (FSC-H).
Adoptive Transfers
Splenocytes from donor mice were harvested and isolated as described in the Lymphocyte Isolation and Flow Cytometry section above. Where indicated, enrichment for CD8 + T cells was performed using a Dynal Mouse CD8 + Negative Isolation Kit (Invitrogen, Carlsbad, CA) per manufacturer's instructions. Cells were counted and 1x10 8 cells were labeled in 5 mL of 15 mM Cell Trace Violet (CTV) (Invitrogen, Carlsbad, CA). Labeling with CTV was done at room temperature for 10 minutes in the dark. Cells were then washed 3 times in cold PBS with 0.1% BSA, counted, and injected i.v. into recipient mice as indicated.
Immune Cell Depletion Depletion of CD8 + T cells was performed using anti-mouse CD8b (Lyt 3.2) antibody, clone 53-5.8 from Bio X Cell, Lebanon, NH. Mice received 2 injections of 200 mg and 2 injections of 500 mg of the antibody i.v. on days À7, À5 and then À3 and 0 relative to challenge infection. For Thy1.1 depletion, anti-mouse Thy1.1 antibody, clone 19E12 was used. Mice received 3 injections of 200 mg IP on days À7, À4, and À2 prior to adoptive transfer.
In Vitro Cytotoxicity The cell killing assay was carried out as previously described (Odorizzi et al., 2015) . Briefly, cells from MLN of naive CD45.1 mice were labeled with 50 nM CTV (''dim'' cells) or 1 mM CTV (''bright'' cells). The CTV dim cells were incubated with 4 mg/ml of P1 519Y peptide, whereas CTV bright cells were incubated with 4 mg/ml of GP33 peptide for 2 hours at 37 C. After two hours, the pulsed cells were washed and 2x10 3 In Vitro MNV-CR6 F/Y Detection Enrichment for CD8 + T cells was carried out using a Dynal Mouse CD8 + Negative Isolation Kit (Invitrogen, Carlsbad, CA) according to manufacturer instructions. Lysis of intestinal preps was carried out via freeze-thaw followed by centrifugation of the sample to remove cell debris. Bone marrow-derived DCs were isolated from the femurs of naive mice and incubated in RPMI 1640 (Corning-Cellgro, Corning, NY) containing 10% fetal bovine serum, 2mM L-glutamine, 50 mM 2-mercaptoethanol, 100 IU/ml penicillin, 100 mg/ml streptomycin, and 20 ng/ml GM-CSF for 6 days with addition of fresh medium every 3 days. + T cells from IELs. Sample purity ranged from 92 to 99%. Sorted cells were resuspended in 700 ml Trizol vortexed for 1 minute, and stored at À80 C pending genomic analysis. RNA from sorted cells was isolated, processed, amplified, labeled, and hybridized to MoGene 2.0 Micorarrays (Affymetrix, Santa Clara, CA) at the Molecular Profiling Facility at the University of Pennsylvania. Affymetrix Expression Console 1.4 software was used to process, quality control, and quantile normalize fluorescent hybridization signals with the Robust Multichip Averaging method as described . Transcripts were log2 normalized. Hierarchical Clustering was performed with Gene Pattern, and Gene Set Enrichment Analysis was performed with GSEA software (Subramanian et al., 2005; Mootha et al., 2003) .
Cell Sorting for Gene Expression Studies
VIRAL TITER MEASUREMENT
Viral titer in fecal pellets and tissues was measured by qPCR using methods and primers previously described (Tomov et al., 2013) .
Quantification and Statistical Analysis
Statistical parameters including number of biological replicates and repeat experiments, data dispersion and precision measures (mean and SEM), and P values for statistical significance by Student's t test and Fisher's exact 2-tailed test are reported in the Figures and Figure Legends . Statistical analysis was performed using GraphPad Prism 7.
DATA AND SOFTWARE AVAILABILITY
The accession number for the MNV Gene Array Data reported in this paper is Gene Expression Omnibus: GSE101429.
